[Re2(CO)8(η1-1-methylimidazol)2] | 1029916-48-0

• 英文名称: [Re2(CO)8(η1-1-methylimidazol)2]
• CAS: 1029916-48-0
• 化学式: C₁₆H₁₂N₄O₈Re₂
• 分子量: 760.707
• InChiKey: QNQBGOKUHFSJNX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为产物：
  描述：

  N-甲基咪唑 、 [Re₂(CO)₈(NCMe)₂] 、 二氯甲烷 以 苯 为溶剂， 以18%的产率得到[Re2(CO)8(η1-1-methylimidazol)2]
  参考文献：
  名称：

  Dirhenium carbonyl complexes bearing 2-vinylpyridine, morpholine and 1-methylimidazole ligands

  摘要：

  Treatment of the labile compound [Re-2(CO)(8)(MeCN)(2)] with 2-vinylpyridine in refluxing benzene affords exclusively the new compound [Re-2(CO)(8)(mu-eta(1):eta(2)- NC5H4CH=CH2)] (1) in 39% yield in which the mu-eta(1):eta(2)-vinylpyridine ligand is coordinated to one Re atom through the nitrogen and to the other Re atom via the olefinic double bond. Reaction of [Re-2(CO)(8)(MeCN)(2)] with morpholine in refluxing benzene furnishes two compounds, [Re-2(CO)(9)(eta(1)-NC4H9O)] (2) and [Re-2(CO)(8)(eta(1)-NC4H9O)(2)] (3) in 5% and 29% yields, respectively. Reaction of [Re-2(CO)(8)(MeCN)(2)] with 1-methylimidazole gives [Re-2(CO)(8){eta(1)-NC3H3N(CH3)}(2)] (4) and the mononuclear compound fac-[ReCl(CO)(3){eta(1)-NC3H3N(CH3)}(2)] (5) in 18% and 26% yields, respectively. In the disubstituted compounds 2 and 4, the heterocyclic ligands occupy equatorial coordination sites. The mononuclear compound 5 consists of three CO groups, two N coordinated eta(1)-1-methylimidazole ligands and a terminal Cl ligand. The XRD structures of complexes 1, 3 and 5 are reported. (C) 2007 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.jorganchem.2007.09.023